PKB is one of the most exciting new molecular targets for the treatment of cancer slimex.biz.

PKB is one of the most exciting new molecular targets for the treatment of cancer, and is a key enzyme in the tumor cells survive mTOR/PI3K/PKB way is dysregulation of those involved in the emergence of resistance of certain cancers to many commonly used anti-cancer drugs slimex.biz .

In addition to its own research programs, Astex has endorsed the productivity in lead discovery through numerous partnerships with major pharmaceutical companies, including AstraZeneca, Bayer-Schering, Boehringer Ingelheim, GlaxoSmithKline, Novartis and Johnson & Johnson.

Paediatric neurologists Rebecca Ichord, the manager of the Pediatric Strokestown the program at Children’s Hospital on Philadelphia, today reported a survey the arterial ischemic stroke with children on International Stroke Conference 2010 at in San Antonio, The conference will sponsored by the American Stroke Association. One of artery ischemic stroke results from a of the constriction or blockade of into the an artery or in the brain.